U.S. markets closed
  • S&P 500

    +8.06 (+0.19%)
  • Dow 30

    +239.57 (+0.71%)
  • Nasdaq

    -25.50 (-0.19%)
  • Russell 2000

    -0.82 (-0.04%)
  • Crude Oil

    -2.55 (-2.85%)
  • Gold

    -7.60 (-0.42%)
  • Silver

    -0.17 (-0.85%)

    +0.0008 (+0.08%)
  • 10-Yr Bond

    +0.0330 (+1.18%)

    +0.0040 (+0.33%)

    +0.9790 (+0.73%)

    -139.24 (-0.58%)
  • CMC Crypto 200

    -2.92 (-0.51%)
  • FTSE 100

    +26.91 (+0.36%)
  • Nikkei 225

    -2.87 (-0.01%)

Proactive news headlines including Tiffany & Co, Cypress Development, American Resources, ImagineAR, Tiziana Life Sciences and Braxia Scientific

·2 min read

New York , Aug. 01, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • CryptoPunks comes to Tiffany & Co. with limited-edition gold pendants click here

  • Todos Medical says new study highlights case for use of dietary supplement product Tollovid click here

  • Cypress Development gets repeat 'Outperform' rating, high-upside $3.10 price target from Noble Capital click here

  • MySize strikes deal with 7 For All Mankind (Brazil) for clothing customers to find perfect fit click here

  • PowerTap Hydrogen Capital provides update on Progressus Clean Technologies subsidiary acquisition by BioQuest click here

  • Alibaba says it will work with US regulators to prevent New York delisting click here

  • Bitcoin and Ethereum keep it steady while DeFi takes a breather click here

  • American Resources says ReElement Technologies division exceeds expectations with greater than 99.5% pure isolated rare earth elements (REE) click here

  • Metal Tiger's investee company notes district opportunity after second significant intersection click here

  • ImagineAR strikes private label mobile app tie-up with London creative agency EngageWorks click here

  • Corporate metaverses will “misfire” says Vitalik Buterin, but venture capital piles in regardless click here

  • Tiziana Life Sciences says study using nasal anti-CD3 (Foralumab) presented at the Alzheimer's Association International Conference click here

  • Xeris Biopharma notes that its commercialization partner for Ogluo in the UK, EEA, and Switzerland, Tetris Pharma, is to be acquired by Arecor Therapeutics click here

  • Braxia Scientific lifts revenue and narrows loss in fiscal 2022 as it looks to "significantly" scale offerings click here

  • Rainbow Rare Earths’ Phalaborwa project may make it the lowest cost producer of neodymium and praseodymium in the world click here

  • Vejii Holdings launches process to review its strategic alternatives click here

About Proactive

Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle. With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors. In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com